Home › Depression › NCT07346638
The BEAR Program for Women With Trauma Who Have Suicidal Thoughts
A Pilot Study of the Building Empowerment and Resilience Program for Suicidal Ideation
Who can join
Ages 18 to 75 · Women
Full eligibility criteria
Inclusion Criteria: * Women ages 18-75 * History of physical, sexual, and/or sexual emotional violence, with subsequent interpersonal or psychological distress (e.g., depression or anxiety) related to this history. * Current suicidal thinking Exclusion Criteria: * Active, significant substance abuse, which could interfere with participation * Significant medical conditions that would preclude safe participation in the study * No history of interpersonal trauma * Acute psychiatric instability * History of assaultive behavior or is judged to be a potential risk to assault others. * No current suicidal ideation or behaviors * Unable to commit to the group for 12 weeks in-person
About the study
The current study aims to test the feasibility of a new form of group therapy for women who have a history of interpersonal trauma and current suicidal ideation. The Building Empowerment and Resilience (BEAR) Therapeutic group has been adapted for women who have experienced trauma and have current suicidal ideation. It incorporates psychological skills, psychoeducation about trauma and gender-based violence, and physical self-defense training, all within a therapeutic process. It will be implemented with women who have experienced interpersonal trauma (physical, sexual, or emotional abuse/neglect) and experience various mental health difficulties, including suicidal ideation. We aim to assess the feasibility to recruit and implement the BEAR group. Our ultimate aim is to assess whether the program can effect self-efficacy and suicidal ideation.
What is being tested
- BEAR-SI (behavioral)
Sponsor: Stanford University · Participants: 30 · Started: Feb 17, 2026
Contact the study team
- Clinical Research Coordinator · Phone: 650-724-7184
Official record on ClinicalTrials.gov — NCT07346638
Locations in the U.S.
| California | Stanford University School of Medicine, Stanford |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.